NeuroPace Inc.

NASDAQ: NPCE · Real-Time Price · USD
8.82
-0.21 (-2.33%)
At close: Aug 15, 2025, 3:07 PM

NeuroPace Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
23.52M 22.52M 21.47M 21.06M 19.26M 18.12M 18.01M 16.43M 16.51M 14.47M 12.79M 11.16M 10.2M 11.37M 11M 10.34M 12.63M 11.22M
Cost of Revenue
5.39M 5.18M 5.28M 5.64M 5.12M 4.78M 4.47M 4.19M 4.54M 4.1M 3.99M 3.19M 2.73M 3.12M 2.92M 2.83M 3.27M 2.72M
Gross Profit
18.13M 17.34M 16.19M 15.42M 14.13M 13.34M 13.54M 12.23M 11.97M 10.37M 8.8M 7.96M 7.47M 8.26M 8.08M 7.51M 9.36M 8.49M
Operating Income
-6.82M -5.15M -3.65M -4.24M -6.23M -7.54M -5.05M -5.95M -7.85M -8.32M -9.86M -10.2M -10.97M -9.76M -9.02M -6.24M -4.61M -3.87M
Interest Income
718K 793K 681K 754K 762K 827K 822K 769K 733K 726K 800K 423K 221K 134K 186K 136K 100K 26K
Pretax Income
-8.65M -6.59M -5.25M -5.45M -7.51M -8.93M -6.2M -7.26M -9.12M -10.38M -11.15M -11.79M -12.69M -11.46M -10.69M -8.08M -8.49M -8.81M
Net Income
n/a -6.59M -5.25M -5.45M -7.51M -8.93M -6.2M -7.26M -9.12M -14.4M -12.43M -13.37M -14.41M -13.16M -10.69M -8.08M -8.49M -8.81M
Selling & General & Admin
18.11M 15.05M 13.79M 13.91M 14.3M 15.1M 13.22M 13.39M 14.48M 13.43M 13.57M 12.55M 12.77M 12.44M 11.75M 9.42M 9.53M 8.27M
Research & Development
6.84M 7.44M 6.05M 5.75M 6.07M 5.78M 5.38M 4.79M 5.34M 5.26M 5.09M 5.61M 5.67M 5.58M 5.34M 4.33M 4.44M 4.1M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a 122K n/a -146K -103K -85K -3K n/a -14K n/a n/a
Operating Expenses
24.96M 22.49M 19.84M 19.66M 20.36M 20.89M 18.6M 18.18M 19.83M 18.69M 18.66M 18.16M 18.44M 18.02M 17.09M 13.75M 13.96M 12.37M
Interest Expense
2.06M 2.15M 2.19M 2.18M 2.17M 2.26M 2.24M 2.19M 2.13M 1.97M 1.94M 1.91M 1.85M 1.83M 1.86M 1.83M 1.87M 1.85M
Selling & Marketing Expenses
12.04M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
30.34M 27.67M 25.12M 25.3M 25.49M 25.67M 23.06M 22.38M 24.36M 22.79M 22.65M 21.36M 21.17M 21.14M 20.01M 16.58M 17.23M 15.09M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a 4.02M 1.29M 1.59M 1.72M 1.7M n/a n/a n/a n/a
Shares Outstanding (Basic)
32.86M 31.48M 29.91M 29.44M 28.85M 28.29M 26.8M 26.02M 25.47M 25.1M 24.83M 24.73M 24.5M 24.31M 24.17M 24.1M 17.55M 22.24M
Shares Outstanding (Diluted)
32.86M 31.48M 29.91M 29.44M 28.85M 28.29M 26.8M 26.02M 25.47M 25.1M 24.83M 24.73M 24.5M 24.31M 24.17M 24.1M 17.55M 22.24M
EPS (Basic)
-0.26 -0.21 -0.18 -0.19 -0.26 -0.32 -0.23 -0.28 -0.36 -0.57 -0.5 -0.54 -0.59 -0.54 -0.44 -0.34 -0.48 -0.4
EPS (Diluted)
-0.26 -0.21 -0.18 -0.19 -0.26 -0.32 -0.23 -0.28 -0.36 -0.57 -0.5 -0.54 -0.59 -0.54 -0.44 -0.34 -0.48 -0.4
EBITDA
-6.82M -3.97M -2.61M -2.82M -4.9M -6.24M -3.56M -4.67M -6.6M -8.02M -8.45M -9.14M -10.09M -8.88M -8.75M -6.16M -6.55M -6.89M
EBIT
-6.59M -4.44M -3.06M -3.27M -5.35M -6.67M -3.96M -5.07M -7M -8.41M -9.21M -9.88M -10.84M -9.63M -8.83M -6.26M -6.62M -6.96M
Depreciation & Amortization
n/a 462K 451K 451K 444K 423K 409K 398K 403K 395K 752K 739K 744K 752K 79K 100K 68K 74K